NCT03239613View on ClinicalTrials.gov

Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

April 28, 2023

Study Completion Date

April 28, 2023

Conditions
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-ModulatedHypofractionated DoseChemotherapy, Concurrent
Interventions
OTHER

POHIM-CCRT

postoperative adjuvant concurrent chemotherapy with hypofractionated IMRT (2.5 Gy/fraction, 16 fractions, once a day)

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03239613 - Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer | Biotech Hunter | Biotech Hunter